𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CCAAT/enhancer binding protein beta is up-regulated in giant cell tumor of bone and regulates RANKL expression

✍ Scribed by Patrick Kwok-Shing Ng; Stephen Kwok-Wing Tsui; Carol Po-Ying Lau; Chi-Hang Wong; Winnie Hiu-Ting Wong; Lin Huang; Shekhar-Madhukar Kumta

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
433 KB
Volume
110
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Giant cell tumor (GCT) of bone is an aggressive non‐cancerous tumor, which consists of multi‐nucleated osteoclast‐like giant cells, stromal cells, and monocytes. It is believed that stromal cells are the neoplastic component of this tumor. Expression of the receptor activator of nuclear factor kappa B ligand (RANKL) in the stromal cells stimulates the monocytes to form giant multi‐nucleated osteoclast‐like cells, causing bone over‐resorption at the tumor site. Previously, our group has reported the up‐regulation of RANKL in GCT of bone stromal cells, but the mechanism is unknown. Using stromal cell culture of GCT obtained from patients, we demonstrated the up‐regulation of the transcriptional activator CCAAT/enhancer binding protein beta (C/EBPβ). RANKL promoter studies revealed that C/EBPβ over‐expression induced RANKL promoter activity in a dose‐dependent manner and a CCAAT‐box within the region nt −357/−1 contributed to the basal transcription activity, with a possible C/EBPβ binding element in the region nt −460/−358 leading to further induction. Furthermore, we also showed that C/EBPβ bound to the RANKL promoter in GCT stromal cells in vivo by chromatin immunoprecipitation. To conclude, our study has shown that C/EBPβ is a RANKL promoter activator in stromal cells of GCT of bone and we have proposed a model in which C/EBPβ plays an important role in the osteolytic characteristics and pathological causes of GCT of bone. J. Cell. Biochem. 110: 438–446, 2010. © 2010 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Extracellular matrix regulates alpha s1-
Extracellular matrix regulates alpha s1-casein gene expression in rabbit primary mammary cells and CCAAT enhancer binding protein (C/EBP) binding activity
✍ Geneviève Jolivet; Chantal Meusnier; Gilles Chaumaz; Louis-Marie Houdebine 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB 👁 1 views

## Abstract Previous studies have shown that both the signal transducer and activator of transcription 5 (STAT5) and the CCAAT enhancer binding proteins (C/EBPs) are involved in the regulation of casein gene expression by mammary epithelial cells. Prolactin (Prl) activation of STAT5 is necessary fo

CCAAT-enhancer-binding protein beta acti
CCAAT-enhancer-binding protein beta activation of MMP-1 gene expression in SW1353 Cells: Independent roles of extracellular signal-regulated and p90/ribosomal S6 kinases
✍ Brenda L. Petrella; David A. Armstrong; Matthew P. Vincenti 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB 👁 1 views

CCAAT-enhancer-binding protein beta (CEBPB) is a pluripotent transcription factor that controls inflammation, proliferation, and differentiation. We recently reported a role for CEBPB during matrix metalloproteinase (MMP) gene expression, but the mechanisms involved are poorly understood. To address

CCAAT/enhancer binding protein δ (C/EBPδ
CCAAT/enhancer binding protein δ (C/EBPδ) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control
✍ G.S. Sivko; D.C. Sanford; L.D. Dearth; D. Tang; J.W. DeWille 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 1 views

## Abstract CCAAT/enhancer binding protein δ (C/EBPδ) plays a key role in mammary epithelial cell G~0~ growth arrest. C/EBPδ gene expression is down‐regulated in rodent mammary tumorigenesis and in human breast cancer, suggesting that “loss of function” alterations in C/EBPδ gene expression are com

Expression and function of CCAAT/enhance
Expression and function of CCAAT/enhancer binding proteinβ (C/EBPβ) LAP and LIP isoforms in mouse mammary gland, tumors and cultured mammary epithelial cells
✍ L.R. Dearth; J. Hutt; A. Sattler; A. Gigliotti; J. DeWille 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB 👁 1 views

## Abstract CCAAT/Enhancer binding proteins (C/EBPs) play important roles in the regulation of cell growth and differentiation. This study investigated the expression and function of C/EBPβ isoforms in the mouse mammary gland, mammary tumors, and a nontransformed mouse mammary epithelial cell line

CCAAT/enhancer binding protein δ (C/EBPδ
CCAAT/enhancer binding protein δ (C/EBPδ) regulation and expression in human mammary epithelial cells: I. “Loss of function” alterations in the C/EBPδ growth inhibitory pathway in breast cancer cell lines
✍ G.S. Sivko; J.W. DeWille 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 1 views

## Abstract “Loss of function” alterations in growth inhibitory signal transduction pathways are common in cancer cells. In this study, we show that growth arrest (GA) treatments—serum and growth factor withdrawal and growth inhibitory IL‐6 family cytokines (Interleukin‐6 and Oncostatin M (OSM))—in